Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
With approximately 400,000 investigator records across more than 117,000 clinical trial sites covering 235+ disease states, Sitetrove brings you the vital information you need to accurately assess target locations, identify qualified investigators, and prioritize candidates to make your trial a success.
How it helps
Clinical trials are costly. The most frequent cause of trial failure? The inability to meet patient enrollment. Reduce this failure risk and lessen the costs associated with investigator identification using Sitetrove.
How it works
Use the vast stores of public information captured by Sitetrove’s team of analysts to inform your clinical trial planning. With extensive, comprehensive data on clinical trials sites and investigators, you can:
Citeline, Sitetrove, Trialtrove, Pharmaprojects
Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.
Sitetrove
Find the right investigators and sites for your clinical trials. For the pharma industry’s most accurate and comprehensive investigator and site intelligence, turn to the invaluable data in Sitetrove. Sitetrove’s team of expert analysts continuously scour over 43,000 public sources to update curated information on the global clinical trial landscape, with content tailored to specific therapeutic areas. Save time and avoid costly delays: find the right investigators in the geographic areas that suit your needs with Sitetrove.
Sitetrove
Find the right investigators and sites for your clinical trials. For the pharma industry’s most accurate and comprehensive investigator and site intelligence, turn to the invaluable data in Sitetrove. Sitetrove’s team of expert analysts continuously scour over 43,000 public sources to update curated information on the global clinical trial landscape, with content tailored to specific therapeutic areas. Save time and avoid costly delays: find the right investigators in the geographic areas that suit your needs with Sitetrove.
Sitetrove
November is National Alzheimer’s Disease (AD) Awareness Month. Sitetrove wants to raise awareness by going purple! This infographic offers an overview of the current global investigator landscape and how AD trial experience has shifted over the last 10 years
Topic Alzheimers
Sitetrove
China’s 13th five-year plan 2016–20 will move the country into the center of the international stage of drug development, where they will be global innovators in the industry and more competitive than ever with foreign firms.
Topic Clinical trials Drug review
Sitetrove
Patient Segmentation, choice not chance webinar recording.
Sitetrove
The halfway mark for 2017 certainly made a splash with Sitetrove growing by 8,230 investigators across 175 countries from January to June.
Topic Diseases
Sitetrove
Choice, not chance : how to mitigate the risk of selecting a non-enrolling site for your clinical trial
Sitetrove
A look at 2016! It was a big year for Sitetrove, Pharma Intelligence’s clinical investigator and trial site solution, as it nears 400,000 clinical investigators.
Topic Clinical trials Diseases
Pharmaprojects, Sitetrove, Trialtrove
The R&D Annual Review webinar is happening soon. Take a look back at pharma R&D in 2016 and look ahead to the remainder of the year to get expert insight from the senior experts at Pharma Intelligence during this free webinar.
Sitetrove
Enrollment success...This is what we all strive for but unfortunately it does not always happen and there is no money-back guarantee.
Topic Clinical trials
Sitetrove
Clinical Trial and Site Selection Optimization for Seasonal Respiratory Vaccines
Topic Clinical Trials
Sitetrove
Applying a data-driven approach to site selection using Sitetrove’s investigator intelligence service can increase average study site enrollment performance. For the actual clinical study
Sitetrove
Applying a data-driven approach to site selection using Sitetrove’s investigator intelligence service can increase average study site enrollment performance. For the actual clinical study
Topic Bivariate analysis
Sitetrove
Applying a data-driven approach to site selection using Sitetrove’sinvestigator intelligence service can increase average study site enrollment performance. For the actual clinical study
USA
USA
Rachel specializes in
+24 year(s) experience
Gail specializes in
+23 year(s) experience
To build and maintain gold-standard, next generation R&D intelligence tools, Sitetrove, Trialtrove, Pharmaprojects, and Trialpredict have been undergoing a major program of investment. In addition to the many new and exciting changes on the horizon, the robust and reliable Citeline tools that you use to inform your business decisions will formally join Informa’s Pharma Intelligence family of brands.
The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Looking for more products Product Finder
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
